Zebrafish: A Model Deciphering the Impact of Flavonoids on Neurodegenerative Disorders

Cells. 2023 Jan 7;12(2):252. doi: 10.3390/cells12020252.

Abstract

Over the past century, advances in biotechnology, biochemistry, and pharmacognosy have spotlighted flavonoids, polyphenolic secondary metabolites that have the ability to modulate many pathways involved in various biological mechanisms, including those involved in neuronal plasticity, learning, and memory. Moreover, flavonoids are known to impact the biological processes involved in developing neurodegenerative diseases, namely oxidative stress, neuroinflammation, and mitochondrial dysfunction. Thus, several flavonoids could be used as adjuvants to prevent and counteract neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Zebrafish is an interesting model organism that can offer new opportunities to study the beneficial effects of flavonoids on neurodegenerative diseases. Indeed, the high genome homology of 70% to humans, the brain organization largely similar to the human brain as well as the similar neuroanatomical and neurochemical processes, and the high neurogenic activity maintained in the adult brain makes zebrafish a valuable model for the study of human neurodegenerative diseases and deciphering the impact of flavonoids on those disorders.

Keywords: Alzheimer; antioxidant; brain; flavonoids; neurodegeneration; neurogenesis; neuroinflammation; neuropathology; neuroplasticity; zebrafish.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Humans
  • Neurodegenerative Diseases* / drug therapy
  • Neurodegenerative Diseases* / metabolism
  • Parkinson Disease* / metabolism
  • Zebrafish / metabolism

Substances

  • Flavonoids

Grants and funding

The research in Zebrafish Neuromorphology Lab was supported by The Regional Department of Agriculture, Rural Development and Mediterranean Fisheries of the Sicily Region, Italy PO FEAMP SICILIA 2014/2020—Project: INNOVITICA; [Grant number: G35F20006240009]. The research in Sepand Rastegar’s lab is supported by the Helmholtz Association BioInterfaces in Technology and Medicine and Natural, Artificial, and Cognitive Information Processing (NACIP) Programs and by project grants of the German Research Foundation (the Deutsche Forschungsgemeinschaft) GRK2039, STR 439/17-1, STR 439/8-2 and RA 3469/5-1. The research in Nicolas Diotel’s lab is supported by the European Regional Development Funds RE0022527 ZEBRATOX (EU-Région Réunion-French State national counterpart).